{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:35:36Z","timestamp":1789094136165,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obesity is a pressing public health concern worldwide. Novel pharmacological means are urgently needed to combat the increase of obesity and accompanying type 2 diabetes (T2D). Although fully established obesity is associated with neuromolecular alterations and insulin resistance in the brain, potential obesity-promoting mechanisms in the central nervous system have remained elusive. In this triple-tracer positron emission tomography study, we investigated whether brain insulin signaling, \u03bc-opioid receptors (MORs) and cannabinoid CB<jats:sub>1<\/jats:sub> receptors (CB<jats:sub>1<\/jats:sub>Rs) are associated with risk for developing obesity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Subjects were 41 young non-obese males with variable obesity risk profiles. Obesity risk was assessed by subjects\u2019 physical exercise habits, body mass index and familial risk factors, including parental obesity and T2D. Brain glucose uptake was quantified with [<jats:sup>18<\/jats:sup>F]FDG during hyperinsulinemic euglycemic clamp, MORs were quantified with [<jats:sup>11<\/jats:sup>C]carfentanil and CB<jats:sub>1<\/jats:sub>Rs with [<jats:sup>18<\/jats:sup>F]FMPEP-<jats:italic>d<\/jats:italic><jats:sub><jats:italic>2<\/jats:italic><\/jats:sub>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Subjects with higher obesity risk had globally increased insulin-stimulated brain glucose uptake (19 high-risk subjects versus 19 low-risk subjects), and familial obesity risk factors were associated with increased brain glucose uptake (38 subjects) but decreased availability of MORs (41 subjects) and CB<jats:sub>1<\/jats:sub>Rs (36 subjects).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results suggest that the hereditary mechanisms promoting obesity may be partly mediated via insulin, opioid and endocannabinoid messaging systems in the brain.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41366-021-00996-y","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T07:02:57Z","timestamp":1635836577000},"page":"400-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Obesity risk is associated with altered cerebral glucose metabolism and decreased \u03bc-opioid and CB1 receptor availability"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-0426","authenticated-orcid":false,"given":"Tatu","family":"Kantonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5596-0485","authenticated-orcid":false,"given":"Laura","family":"Pekkarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Karjalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Kalliokoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja","family":"Haaparanta-Solin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-514X","authenticated-orcid":false,"given":"Richard","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"von Eyken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-8118","authenticated-orcid":false,"given":"Kirsi","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Houttu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Kirjavainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapani","family":"R\u00f6nnemaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-338X","authenticated-orcid":false,"given":"Pirjo","family":"Nuutila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Nummenmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"996_CR1","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"L Abarca-G\u00f3mez","year":"2017","unstructured":"Abarca-G\u00f3mez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390:2627\u201342.","journal-title":"Lancet"},{"key":"996_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal LF, Mertens IL, De, Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875\u201380.","journal-title":"Nature"},{"key":"996_CR3","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","volume":"62","author":"M Kivipelto","year":"2005","unstructured":"Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62:1556\u201360.","journal-title":"Arch Neurol"},{"key":"996_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jpeds.2011.03.021","volume":"159","author":"J Juhola","year":"2011","unstructured":"Juhola J, Magnussen CG, Viikari JSA, K\u00e4h\u00f6nen M, Hutri-K\u00e4h\u00f6nen N, Jula A, et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the cardiovascular risk in Young Finns study. J Pediatr. 2011;159:584\u201390.","journal-title":"J Pediatr"},{"key":"996_CR5","first-page":"S1","volume":"23","author":"TJ Parsons","year":"1999","unstructured":"Parsons TJ, Power C, Logan S, Summerbell CD. Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord. 1999;23:S1\u2013S107.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"996_CR6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/01.ATV.9.6.928","volume":"9","author":"SM Haffner","year":"1989","unstructured":"Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E. Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis. 1989;9:928\u201333.","journal-title":"Arteriosclerosis"},{"key":"996_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.metabol.2008.10.006","volume":"58","author":"RM Anjana","year":"2009","unstructured":"Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V. Parental history of type 2 diabetes mellitus, metabolic syndrome, and cardiometabolic risk factors in Asian Indian adolescents. Metabolism. 2009;58:344\u201350.","journal-title":"Metabolism"},{"key":"996_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/sj.ijo.0803459","volume":"31","author":"X Yang","year":"2007","unstructured":"Yang X, Telama R, Leskinen E, Mansikkaniemi K, Viikari J, Raitakari OT. Testing a model of physical activity and obesity tracking from youth to adulthood: the cardiovascular risk in young Finns study. Int J Obes. 2007;31:521\u20137.","journal-title":"Int J Obes"},{"key":"996_CR9","doi-asserted-by":"publisher","first-page":"E1542","DOI":"10.1210\/jc.2011-1243","volume":"96","author":"M Juonala","year":"2011","unstructured":"Juonala M, Juhola J, Magnussen CG, W\u00fcrtz P, Viikari JSA, Thomson R, et al. Childhood environmental and genetic predictors of adulthood obesity: the cardiovascular risk in Young Finns study. J Clin Endocrinol Metab. 2011;96:E1542\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"996_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1210\/jc.2011-2525","volume":"97","author":"SJ Guyenet","year":"2012","unstructured":"Guyenet SJ, Schwartz MW. Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab. 2012;97:745\u201355.","journal-title":"J Clin Endocrinol Metab"},{"key":"996_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tem.2009.08.004","volume":"21","author":"JF Davis","year":"2010","unstructured":"Davis JF, Choi DL, Benoit SC. Insulin, leptin and reward. Trends Endocrinol Metabol. 2010;21:68\u201374.","journal-title":"Trends Endocrinol Metabol"},{"key":"996_CR12","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2337\/db12-1460","volume":"62","author":"JJ Tuulari","year":"2013","unstructured":"Tuulari JJ, Karlsson HK, Hirvonen J, Hannukainen JC, Bucci M, Helmio M, et al. Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese. Diabetes. 2013;62:2747\u201351.","journal-title":"Diabetes"},{"key":"996_CR13","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.2337\/db06-0376","volume":"55","author":"K Anthony","year":"2006","unstructured":"Anthony K, Reed LJ, Dunn JT, Bingham E, Hopkins D, Marsden PK, et al. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes. 2006;55:2986\u201392.","journal-title":"Diabetes"},{"key":"996_CR14","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1038\/ijo.2009.73","volume":"33","author":"BA Gosnell","year":"2009","unstructured":"Gosnell BA, Levine AS. Reward systems and food intake: role of opioids. Int J Obes. 2009;33:S54\u20138.","journal-title":"Int J Obes"},{"key":"996_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","volume":"26","author":"MR Yeomans","year":"2002","unstructured":"Yeomans MR, Gray RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev. 2002;26:713\u201328.","journal-title":"Neurosci Biobehav Rev"},{"key":"996_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/mp.2015.153","volume":"21","author":"HK Karlsson","year":"2016","unstructured":"Karlsson HK, Tuulari JJ, Tuominen L, Hirvonen J, Honka H, Parkkola R, et al. Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity. Mol Psychiatry. 2016;21:1057\u201362.","journal-title":"Mol Psychiatry"},{"key":"996_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0269881111408458","volume":"26","author":"FJ Bermudez-Silva","year":"2012","unstructured":"Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol. 2012;26:114\u201324.","journal-title":"J Psychopharmacol"},{"key":"996_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","volume":"64","author":"R Mechoulam","year":"2013","unstructured":"Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013;64:21\u201347.","journal-title":"Annu Rev Psychol"},{"key":"996_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"TC Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, Marzo VD. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002;136:550\u20137.","journal-title":"Br J Pharmacol"},{"key":"996_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","volume":"28","author":"C Ravinet Trillou","year":"2004","unstructured":"Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubri\u00e9 P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes. 2004;28:640\u20138.","journal-title":"Int J Obes"},{"key":"996_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-004-1877-8","volume":"176","author":"C Sanchis-Segura","year":"2004","unstructured":"Sanchis-Segura C, Cline BH, Marsicano G, Lutz B, Spanagel R. Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology. 2004;176:223\u201332.","journal-title":"Psychopharmacology"},{"key":"996_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0006-8993(02)03245-6","volume":"952","author":"JA Harrold","year":"2002","unstructured":"Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G. Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res. 2002;952:232\u20138.","journal-title":"Brain Res"},{"key":"996_CR23","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1523\/JNEUROSCI.4744-14.2015","volume":"35","author":"HK Karlsson","year":"2015","unstructured":"Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S, et al. Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain. J Neurosci. 2015;35:3959\u201365.","journal-title":"J Neurosci"},{"key":"996_CR24","first-page":"235","volume":"27","author":"K Hamacher","year":"1986","unstructured":"Hamacher K, Coenen HH, St\u00f6cklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235\u20138.","journal-title":"J Nucl Med"},{"key":"996_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jlcr.572","volume":"45","author":"C Lemaire","year":"2002","unstructured":"Lemaire C, Damhaut P, Lauricella B, Mosdzianowski C, Morelle JL, Monclus M, et al. Fast [18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support. J Label Compd Radiopharm. 2002;45:435\u201347.","journal-title":"J Label Compd Radiopharm"},{"key":"996_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2310\/7290.2015.00019","volume":"14","author":"O Eriksson","year":"2015","unstructured":"Eriksson O, Antoni G. [11C]Carfentanil binds preferentially to mu-opioid receptor subtype 1 compared to subtype 2. Mol Imaging. 2015;14:476\u201383.","journal-title":"Mol Imaging"},{"key":"996_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0969-8043(96)00177-7","volume":"48","author":"P Larsen","year":"1997","unstructured":"Larsen P, Ulin J, Dahlstr\u00f8m K, Jensen M. Synthesis of [11C] iodomethane by iodination of [11C] methane. Appl Radiat Isot. 1997;48:153\u20137.","journal-title":"Appl Radiat Isot"},{"key":"996_CR28","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/0883-2889(92)90012-4","volume":"43","author":"DM Jewett","year":"1992","unstructured":"Jewett DM. A simple synthesis of [11C] methyl triflate. Int J Radiat Appl Instrum. 1992;43:1383\u20135.","journal-title":"Int J Radiat Appl Instrum"},{"key":"996_CR29","doi-asserted-by":"crossref","unstructured":"Lahdenpohja S, Keller T, Forsback S, Viljanen T, Kokkom\u00e4ki E, Kivel\u00e4 RV, et al. Automated GMP production and long\u2010term experience in radiosynthesis of CB1 tracer [18F] FMPEP\u2010d2. J Label Compd Radiopharm. 2020;63:408\u201318.","DOI":"10.1002\/jlcr.3845"},{"key":"996_CR30","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol-Endocrinol Metab. 1979;237:E214.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"996_CR31","doi-asserted-by":"crossref","unstructured":"Karjalainen T, Tuisku J, Santavirta S, Kantonen T, Bucci M, Tuominen L, et al. Magia: robust automated image processing and kinetic modeling toolbox for PET neuroinformatics. Front Neuroinform. 2020;14:3.","DOI":"10.3389\/fninf.2020.00003"},{"key":"996_CR32","first-page":"711","volume":"36","author":"JA Thie","year":"1995","unstructured":"Thie JA. Clarification of a fractional uptake concept. J Nucl Med. 1995;36:711\u20132.","journal-title":"J Nucl Med"},{"key":"996_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"996_CR34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/jcbfm.1989.59","volume":"9","author":"JJ Frost","year":"1989","unstructured":"Frost JJ, Douglass KH, Mayberg HS, Dannals RF, Links JM, Wilson AA, et al. Multicompartmental analysis of [11C]-Carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab. 1989;9:398\u2013409.","journal-title":"J Cereb Blood Flow Metab"},{"key":"996_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","volume":"27","author":"J Logan","year":"2000","unstructured":"Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nuclear Med Biol. 2000;27:661\u201370.","journal-title":"Nuclear Med Biol"},{"key":"996_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-020-00110-7","volume":"6","author":"AM Dickens","year":"2020","unstructured":"Dickens AM, Borgan F, Laurikainen H, Lamichhane S, Marques T, R\u00f6nkk\u00f6 T, et al. Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis. npj Schizophr. 2020;6:1\u201310.","journal-title":"npj Schizophr"},{"key":"996_CR37","doi-asserted-by":"publisher","first-page":"116922","DOI":"10.1016\/j.neuroimage.2020.116922","volume":"217","author":"T Kantonen","year":"2020","unstructured":"Kantonen T, Karjalainen T, Isoj\u00e4rvi J, Nuutila P, Tuisku J, Rinne J, et al. Interindividual variability and lateralization of \u03bc-opioid receptors in the human brain. NeuroImage. 2020;217:116922.","journal-title":"NeuroImage"},{"key":"996_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1176\/ajp.156.6.842","volume":"156","author":"JK Zubieta","year":"1999","unstructured":"Zubieta JK, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry. 1999;156:842\u20138.","journal-title":"Am J Psychiatry"},{"key":"996_CR39","first-page":"1141","volume":"36","author":"A Loessner","year":"1995","unstructured":"Loessner A, Alavi A, Lewandrowski K-U, Mozley D, Souder E, Gur R. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med. 1995;36:1141\u20139.","journal-title":"J Nucl Med"},{"key":"996_CR40","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/hbm.22298","volume":"35","author":"L Tuominen","year":"2014","unstructured":"Tuominen L, Nummenmaa L, Keltikangas\u2010J\u00e4rvinen L, Raitakari O, Hietala J. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems. Hum Brain Mapp. 2014;35:1875\u201384.","journal-title":"Hum Brain Mapp"},{"key":"996_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2011.82","volume":"17","author":"J Hirvonen","year":"2012","unstructured":"Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2012;17:642\u20139.","journal-title":"Mol Psychiatry"},{"key":"996_CR42","first-page":"189","volume":"5","author":"A Gelman","year":"2012","unstructured":"Gelman A, Hill J, Yajima M. Why we (usually) don\u2019t have to worry about multiple comparisons. J Res Educ Effect. 2012;5:189\u2013211.","journal-title":"J Res Educ Effect"},{"key":"996_CR43","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.280.5368.1371","volume":"280","author":"JO Hill","year":"1998","unstructured":"Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998;280:1371\u20134.","journal-title":"Science"},{"key":"996_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1365-2796.2003.01242.x","volume":"254","author":"RJ Loos","year":"2003","unstructured":"Loos RJ, Bouchard C. Obesity\u2014is it a genetic disorder? J Intern Med. 2003;254:401\u201325.","journal-title":"J Intern Med"},{"key":"996_CR45","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1007\/s00125-009-1501-x","volume":"52","author":"M Hallschmid","year":"2009","unstructured":"Hallschmid M, Schultes B. Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? Diabetologia. 2009;52:2264\u20139.","journal-title":"Diabetologia"},{"key":"996_CR46","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/jcm10071532","volume":"10","author":"E Rebelos","year":"2021","unstructured":"Rebelos E, Rinne JO, Nuutila P, Ekblad LL. Brain glucose metabolism in health, obesity, and cognitive decline\u2014does insulin have anything to do with it? A narrative review. J Clin Med. 2021;10:1532.","journal-title":"J Clin Med"},{"key":"996_CR47","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","volume":"96","author":"S Kullmann","year":"2016","unstructured":"Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Haring HU. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev. 2016;96:1169\u2013209.","journal-title":"Physiol Rev"},{"key":"996_CR48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.neuroimage.2008.02.031","volume":"41","author":"LE Stoeckel","year":"2008","unstructured":"Stoeckel LE, Weller RE, Cook EW 3rd, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. Neuroimage. 2008;41:636\u201347.","journal-title":"Neuroimage"},{"key":"996_CR49","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/npp.2016.265","volume":"42","author":"J Majuri","year":"2017","unstructured":"Majuri J, Joutsa J, Johansson J, Voon V, Alakurtti K, Parkkola R, et al. Dopamine and opioid neurotransmission in behavioral addictions: a comparative PET study in pathological gambling and binge eating. Neuropsychopharmacology. 2017;42:1169\u201377.","journal-title":"Neuropsychopharmacology"},{"key":"996_CR50","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/alcalc\/agt050","volume":"48","author":"N Rouvinen-Lagerstr\u00f6m","year":"2013","unstructured":"Rouvinen-Lagerstr\u00f6m N, Lahti J, Alho H, Kovanen L, Aalto M, Partonen T, et al. \u00b5-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. Alcohol Alcohol. 2013;48:519\u201325.","journal-title":"Alcohol Alcohol"},{"key":"996_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/S146114571200017X","volume":"16","author":"EM Weerts","year":"2013","unstructured":"Weerts EM, McCaul ME, Kuwabara H, Yang X, Xu X, Dannals RF, et al. Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects. Int J Neuropsychopharmacol. 2013;16:47\u201353.","journal-title":"Int J Neuropsychopharmacol"},{"key":"996_CR52","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/oby.2009.52","volume":"17","author":"CA Davis","year":"2009","unstructured":"Davis CA, Levitan RD, Reid C, Carter JC, Kaplan AS, Patte KA, et al. Dopamine for \u201cwanting\u201d and opioids for \u201cliking\u201d: a comparison of obese adults with and without binge eating. Obesity. 2009;17:1220\u20135.","journal-title":"Obesity"},{"key":"996_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03848-y","volume":"9","author":"L Nummenmaa","year":"2018","unstructured":"Nummenmaa L, Saanijoki T, Tuominen L, Hirvonen J, Tuulari JJ, Nuutila P, et al. \u03bc-opioid receptor system mediates reward processing in humans. Nat Commun. 2018;9:1500.","journal-title":"Nat Commun"},{"key":"996_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01559-5","volume":"11","author":"T Kantonen","year":"2021","unstructured":"Kantonen T, Karjalainen T, Pekkarinen L, Isoj\u00e4rvi J, Kalliokoski K, Kaasinen V, et al. Cerebral \u03bc-opioid and CB1 receptor systems have distinct roles in human feeding behavior. Transl Psychiatry. 2021;11:442.","journal-title":"Transl Psychiatry"},{"key":"996_CR55","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.1523\/JNEUROSCI.0976-17.2017","volume":"37","author":"JJ Tuulari","year":"2017","unstructured":"Tuulari JJ, Tuominen L, de Boer FE, Hirvonen J, Helin S, Nuutila P, et al. Feeding releases endogenous opioids in humans. J Neurosci. 2017;37:8284\u201391.","journal-title":"J Neurosci"},{"key":"996_CR56","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","volume":"134","author":"N Jamshidi","year":"2001","unstructured":"Jamshidi N, Taylor DA. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol. 2001;134:1151\u20134.","journal-title":"Br J Pharmacol"},{"key":"996_CR57","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/sj.npp.1301376","volume":"32","author":"SV Mahler","year":"2007","unstructured":"Mahler SV, Smith KS, Berridge KC. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances \u2018liking\u2019 of a sweet reward. Neuropsychopharmacology. 2007;32:2267\u201378.","journal-title":"Neuropsychopharmacology"},{"key":"996_CR58","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S Engeli","year":"2005","unstructured":"Engeli S, B\u00f6hnke J, Feldpausch M, Gorzelniak K, Janke J, B\u00e1tkai S, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005;54:2838.","journal-title":"Diabetes"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00996-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T16:04:23Z","timestamp":1666973063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00996-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1038\/s41366-021-00996-y","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}